Scientists on the cutting edge of biomedical research know that research is a process — a combination of successes and failures that inform the next step forward. However, for some researchers at The Ohio State University, progress means taking a step back. Supported by the Ohio State University Center for Clinical and Translational Science (CCTS), these scientists are using failed and forgotten research to uncover future treatments for major health conditions as diverse as oral cancer and stroke.
One such "step back" is rethinking fenretinide for prevention of oral cancer.
Click here to read the article.
